Cited 0 time in
LONG-TERM EFFICACY AND SAFETY OF GOLIMUMAB, A HUMAN ANTI-TNF ALPHA MONOCLONAL ANTIBODY, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY: RESULTS FROM THE GO-FORWARD STUDY
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 배상철 | - |
| dc.date.accessioned | 2021-08-03T19:22:58Z | - |
| dc.date.available | 2021-08-03T19:22:58Z | - |
| dc.date.issued | 2010-07-16 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/58130 | - |
| dc.title | LONG-TERM EFFICACY AND SAFETY OF GOLIMUMAB, A HUMAN ANTI-TNF ALPHA MONOCLONAL ANTIBODY, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY: RESULTS FROM THE GO-FORWARD STUDY | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | EULAR | - |
| dc.citation.conferencePlace | Kilchberg Switzerland. | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
